← Leaderboards
Margaret M Madeleine
Fred Hutchinson Cancer Research Center
$13,649,862
Attributed
$20,072,608
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,234,206 · 17
By mechanism
U54$18,470,783 · 10
R01$9,085,029 · 3
P01$2,021,394 · 2
R21$484,000 · 1
R03$173,000 · 1
Top collaborators
- Robinson Cabello24 shared
- Ann C Duerr24 shared
- Anna Wald10 shared
- Marie Marcelle H. Deschamps6 shared
- Yeycy A. Donastorg6 shared
- Corey Casper4 shared
- Denise A. Galloway4 shared
- David Wang4 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Janet R Daling$9,948,750
- Ying Qing Chen$12,344,940
- Stephen Marc Schwartz$21,149,027
- Chu Chen$16,558,917
- Ann C Duerr$21,182,270
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsWomanVaccinationClinical TrialsPremalignantLesionPreventionLaboratoriesHuman Papilloma Virus VaccineScreeningResourcesResearch PersonnelPeruSamplingMalignant Neoplasm Of Cervix UteriCervical Cancer PreventionTriageDominican RepublicMonitorInterruptionChildHuman PapillomavirusProgramsInfrastructure
Grant awards (70)
Colaboración Evita: Cervical Cancer Prevention Partnership Center$689,186
U54 · FY2025 · CA · contact PI
Administrative and Coordinating Core$689,186
U54 · FY2025 · CA · contact PI
Administrative and Coordinating Core$140,344
U54 · FY2025 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$140,344
U54 · FY2025 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$124,182
U54 · FY2025 · CA · contact PI
Administrative and Coordinating Core$124,182
U54 · FY2025 · CA · contact PI
Administrative and Coordinating Core$46,288
U54 · FY2025 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$46,288
U54 · FY2025 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$1,552,556
U54 · FY2024 · CA · contact PI
Project-002$360,646
U54 · FY2024 · CA · contact PI
Clinical Trials Program$337,247
U54 · FY2024 · CA · contact PI
Project-001$266,150
U54 · FY2024 · CA · contact PI
Administrative and Coordinating Core$257,149
U54 · FY2024 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$1,897,572
U54 · FY2023 · CA · contact PI
Project-002$475,984
U54 · FY2023 · CA · contact PI
Clinical Trials Program$401,630
U54 · FY2023 · CA · contact PI
Administrative and Coordinating Core$329,133
U54 · FY2023 · CA · contact PI
Project-001$234,732
U54 · FY2023 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$780,737
R01 · FY2022 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$334,104
U54 · FY2022 · CA · contact PI
Project-002$117,064
U54 · FY2022 · CA · contact PI
Clinical Trials Program$56,376
U54 · FY2022 · CA · contact PI
Administrative and Coordinating Core$50,416
U54 · FY2022 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$1,000,000
U54 · FY2021 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$803,006
U54 · FY2021 · CA · contact PI
Clinical Trials Program$257,166
U54 · FY2021 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$227,161
R01 · FY2021 · CA · contact PI
Project-001$226,643
U54 · FY2021 · CA · contact PI
Project-002$215,903
U54 · FY2021 · CA · contact PI
Administrative and Coordinating Core$209,586
U54 · FY2021 · CA · contact PI
Clinical Trials Program$199,636
U54 · FY2021 · CA · contact PI
Project-001$165,385
U54 · FY2021 · CA · contact PI
Project-002$159,204
U54 · FY2021 · CA · contact PI
Administrative and Coordinating Core$129,196
U54 · FY2021 · CA · contact PI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center$1,736,491
U54 · FY2020 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$765,488
R01 · FY2020 · CA · contact PI
Clinical Trials Program$532,741
U54 · FY2020 · CA · contact PI
Project-001$427,763
U54 · FY2020 · CA · contact PI
Administrative and Coordinating Core$366,313
U54 · FY2020 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$251,374
R01 · FY2020 · CA · contact PI
Project-002$150,690
U54 · FY2020 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$134,231
R01 · FY2020 · CA · contact PI
Cervical Cancer Prevention in Peru and the Dominican Republic$1,837,869
U54 · FY2019 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$707,409
R01 · FY2019 · CA · contact PI
Clinical Trials Program$597,253
U54 · FY2019 · CA · contact PI
Project-001$376,080
U54 · FY2019 · CA · contact PI
Administrative and Coordinating Core$331,360
U54 · FY2019 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$108,522
R01 · FY2019 · CA · contact PI
Project-002$77,739
U54 · FY2019 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$753,320
R01 · FY2018 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$88,149
R01 · FY2018 · CA · contact PI
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial$767,849
R01 · FY2017 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$371,081
R01 · FY2015 · CA
Post GWA Analysis of Inflammation Pathways in Barrett's and Esophageal Cancer$264,000
R21 · FY2015 · DK · contact PI
Novel Pathogen Associated Cancers (PQ12)$722,856
R01 · FY2014 · CA
Post GWA Analysis of Inflammation Pathways in Barrett's and Esophageal Cancer$220,000
R21 · FY2014 · DK · contact PI
Novel Pathogen Associated Cancers (PQ12)$736,412
R01 · FY2013 · CA
Novel Pathogen Associated Cancers (PQ12)$784,723
R01 · FY2012 · CA
EPIDEMIOLOGY OF HPV-RELATED SCSC IN TRANSPLANT PATIENTS$431,667
P01 · FY2011 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT$330,810
P01 · FY2011 · CA · contact PI
Inflammation Pathways in Breast Cancer$430,597
R01 · FY2010 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT$342,399
P01 · FY2010 · CA · contact PI
Inflammation Pathways in Breast Cancer$567,887
R01 · FY2009 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT$315,813
P01 · FY2009 · CA · contact PI
Inflammation Pathways in Breast Cancer$504,546
R01 · FY2008 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT$307,392
P01 · FY2008 · CA · contact PI
Inflammation Pathways in Breast Cancer$382,687
R01 · FY2007 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT$293,313
P01 · FY2007 · CA · contact PI
Chlamydia trachomatis and Cervical Cancer$86,500
R03 · FY2003 · CA
Chlamydia trachomatis and Cervical Cancer$86,500
R03 · FY2002 · CA